Stevens Raymond C's Form 4 filing
Structure Therapeutics Inc. (GPCR) · filed Jun 12, 2024
- Accession no.
- 0001415889-24-016510
- Filed
- Jun 12, 2024
- Trade date
- Jun 10, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 2 derivative transactions. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Stevens Raymond CCIK 0001698149 | Director, Officer (CHIEF EXECUTIVE OFFICER) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 10, 2024 | Ordinary Shares | CConversionDisposed | −555,000 | $0.00 | $0 | 643,346 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 10, 2024 | Ordinary Shares | CConversionAcquired | +555,000 | $0.00 | $0 | 185,000 | Direct | |
| Jun 10, 2024 | Ordinary Shares | SSaleDisposed | −555,000 | $52.80 | −$9,768,000 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.